CACLP - The largest IVD Expo & Conference

FDA Grants EUAs for SARS-CoV-2 Tests, Kits From Exact Sciences, BioGx, Bio-Rad, Everlywell

Industry news | 05 July, 2021 | CACLP


Original from Genomeweb

 

The US Food and Drug Administration recently granted separate Emergency Use Authorization for molecular SARS-CoV-2 tests from Exact Sciences and BioGx, an immunoassay for detecting the virus from Bio-Rad Laboratories, and an at-home specimen collection kit from Everlywell.

 

Exact's COVID-Flu Multiplex Assay is designed for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A, and influenza B in anterior nasal swabs self-collected in a healthcare setting.

 

The RT-PCR-based test may also be used with anterior nasal swab specimens self-collected at home using the Exact Sciences Nasal Swab Home Collection Kit or the newly authorized Everlywell COVID-19 & Flu Test Home Collection Kit.

 


Exact's test may be performed only at the Madison, Wisconsin-based company's CLIA lab, according to the FDA. Everlywell's collection kit is only for use by CLIA labs designed by Everlywell.

 

The BioGx Xfree COVID-19 Direct RT-PCR assay is designed to detect SARS-CoV-2 nucleic acid in nasopharyngeal, anterior nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate, or nasal aspirates collected by a healthcare provider.

 

According to Birmingham, Alabama-based BioGx, patient samples can be added directly to a vial containing all RT-PCR reagents without the need for preprocessing or nucleic acid extraction.

 

It may be used by any lab CLIA-certified to perform high-complexity tests, the FDA said.

 

Bio-Rad's BioPlex 2200 SARS-CoV-2 IgG is designed for the qualitative and semi-quantitative detection of immunoglobulin G against SARS-CoV-2 in serum and plasma. The automated assay, which runs on the Hercules, California-based firm's BioPlex 2200 system, may be used by any lab CLIA-certified to perform moderate- or high-complexity tests.


View source version on: https://www.genomeweb.com/molecular-diagnostics/fda-grants-euas-sars-cov-2-tests-kits-exact-sciences-biogx-bio-rad-everlywell#.YOLEkS21F0t


Filed under:
FDA
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference